企業プロフィール
Shockwave Medical 株価・ニュース・カタリスト
- ティッカー:
- SWAV
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for SWAV.
企業概要
事業概要
Shockwave Medical was a medical technology company focused on intravascular lithotripsy for cardiovascular disease before being acquired by Johnson & Johnson. Its platform changed how clinicians approached calcium-related vessel treatment.
所在地とセクター分類
Shockwave was headquartered in the United States and listed on NASDAQ before the acquisition. It sat in high-growth cardiovascular medtech rather than biotech.
ビジネスモデルの特徴
The company generated value through procedure adoption, product expansion, and the widening use of its lithotripsy platform. Investors watched procedural growth, international adoption, and system penetration.
バイオ業界での位置付け
Shockwave was outside biotech but was one of the most important procedure-driven medtech growth names. Because it has been acquired, it is now a historical reference point rather than a live public company.
今後のカタリスト
- Shockwave’s catalyst story is still intravascular lithotripsy adoption and how the franchise is being integrated into the broader commercial footprint. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。